Van Lanschot Kempen Wealth Management N.V.
9.3.2021 08:31:28 CET | Globenewswire | Press release
Amsterdam/’s-Hertogenbosch, the Netherlands, 9 March 2021
In the period from 2 March 2021 until 8 March 2021 Van Lanschot Kempen has repurchased 16,381 of its own shares (depositary receipts for Class A ordinary shares). The shares were repurchased at an average price of €21.80 per share for a total amount of €358,433.
These repurchases are part of the share buy-back programme for at most 400,000 of own shares, which was announced on 25 February 2021. The total number of shares repurchased to date is 41,381.
More information, including a detailed overview of the repurchase transactions under this programme, is available on www.vanlanschotkempen.com/sharebuyback.
Media Relations: +31 20 354 45 85; mediarelations@vanlanschotkempen.com
Investor Relations: +31 20 354 45 90; investorrelations@vanlanschotkempen.com
About Van Lanschot Kempen
Van Lanschot Kempen, a wealth manager operating under the Van Lanschot, Kempen and Evi brand names, is active in Private Banking, Asset Management and Merchant Banking, with the aim of preserving and creating wealth, in a sustainable way, for both its clients and the society of which it is part. Van Lanschot Kempen, listed at Euronext Amsterdam, is the Netherlands’ oldest independent financial services company with a history dating back to 1737.
For more information, please visit vanlanschotkempen.com
Disclaimer
This press release does not constitute an offer or solicitation for the sale, purchase or acquisition in any other way or subscription to any financial instrument and is not a recommendation to perform or refrain from performing any action.
This press release is a translation of the Dutch language original and is provided as a courtesy only. In the event of any disparities, the Dutch language version will prevail. No rights can be derived from any translation thereof.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Danske Invest24.9.2026 09:04:52 CEST | Press release
Anmodning om ophør af suspension i enkelte afdelinger under Investeringsforeningen Danske Invest og Investeringsforeningen Danske Invest Select
Investeringsforeningen BankInvest24.9.2026 09:00:00 CEST | Pressemeddelelse
Anmodning om suspension for andelsklasser under Investeringsforeningen BankInvest
Nykredit Realkredit A/S24.9.2026 08:57:35 CEST | Press release
Announcement of drawings (CK95) - Nykredit Realkredit A/S
Nykredit Realkredit A/S24.9.2026 08:57:35 CEST | Pressemeddelelse
Udtrækningsmeddelelse (CK95) - Nykredit Realkredit A/S
AGC Biologics, Inc.24.9.2026 08:55:00 CEST | Press release
Flen Health Chooses AGC Biologics to Manufacture Recombinant Enzymes for Next-Generation Wound Treatment
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
